» Articles » PMID: 9408097

Prevalence of Orthostatic Hypotension in Parkinson's Disease

Overview
Date 1998 Jan 4
PMID 9408097
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate the prevalence of orthostatic hypotension and the nature of the postural events related to a fall in blood pressure in patients with Parkinson's disease.

Methods: Blood pressure was measured first in a supine position after a rest of at least 15 minutes and every minute during 10 minutes of an active standing up procedure. Orthostatic hypotension was considered as present when a fall of at least 20 mm Hg of systolic blood pressure was recorded. Postural events which occurred during the standing test were identified from a questionnaire and self reporting. Statistical analysis was performed to determine the relation between orthostatic hypotension and disease characteristics (duration, severity) and the use of antiparkinsonian drugs. Ninety one consecutive patients with Parkinson's disease (48 women, 43 men, mean age 66 (SD 9) years) participated to the study.

Results: A fall of at least 20 mm Hg of systolic blood pressure was found in 58.2% of the patients. Orthostatic hypotension was asymptomatic in 38.5% and associated with postural events in 19.8% of the patients. Symptomatic (but not asymptomatic) orthostatic hypotension was related to duration and severity of the disease and with the use of higher daily levodopa and bromocriptine doses. The analysis of the relation between the postural symptoms (and the need for standing test abortion) with the fall in systolic blood pressure allowed the identification of six clinical criteria specific of orthostatic hypotension. A direct relation between the postural changes in systolic blood pressure and the number of clinical events in this clinical scale was found.

Conclusion: The frequency of orthostatic hypotension in Parkinson's disease is high and it is possible to establish a clinical rating scale which could be used to assess the effects of drugs employed in the management of orthostatic hypotension.

Citing Articles

Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson's Disease.

Crispo J, Farhat N, Fortin Y, Perez-Lloret S, Sikora L, Morgan R Brain Sci. 2024; 14(8).

PMID: 39199470 PMC: 11352331. DOI: 10.3390/brainsci14080776.


Longitudinal prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative (PPMI) cohort.

Beach P, McKay J Auton Neurosci. 2024; 253:103173.

PMID: 38692034 PMC: 11128342. DOI: 10.1016/j.autneu.2024.103173.


The Association between Parkinson's Disease and Congestive Heart Failure in Korea: A Nationwide Longitudinal Cohort Study.

Kim J, Kim H, Kim S, Kim W, Sheen S, Han I J Pers Med. 2023; 13(9).

PMID: 37763125 PMC: 10532512. DOI: 10.3390/jpm13091357.


Persistent Orthostatic Hypotension Following Surgery for Adult Spinal Deformity: Prevalence, Risk Factors, and Cardiovascular Evaluation.

Takano M, Iida T, Hikata T Asian Spine J. 2023; 17(4):685-692.

PMID: 37408295 PMC: 10460655. DOI: 10.31616/asj.2022.0296.


Neurological update: non-motor symptoms in atypical parkinsonian syndromes.

Ananthavarathan P, Patel B, Peeros S, Obrocki R, Malek N J Neurol. 2023; 270(9):4558-4578.

PMID: 37316556 PMC: 10421812. DOI: 10.1007/s00415-023-11807-x.


References
1.
Chan V, LANDON J . Urinary thyroxine excretion as index of thyroid function. Lancet. 1972; 1(7740):4-6. DOI: 10.1016/s0140-6736(72)90002-5. View

2.
HOEHN M, Yahr M . Parkinsonism: onset, progression and mortality. Neurology. 1967; 17(5):427-42. DOI: 10.1212/wnl.17.5.427. View

3.
Kuroiwa Y, Shimada Y, TOYOKURA Y . Postural hypotension and low R-R interval variability in parkinsonism, spino-cerebellar degeneration, and Shy-Drager syndrome. Neurology. 1983; 33(4):463-7. DOI: 10.1212/wnl.33.4.463. View

4.
Sachs C, Berglund B, Kaijser L . Autonomic cardiovascular responses in parkinsonism: effect of levodopa with dopa-decarboxylase inhibition. Acta Neurol Scand. 1985; 71(1):37-42. DOI: 10.1111/j.1600-0404.1985.tb03164.x. View

5.
Goetz C, Lutge W, Tanner C . Autonomic dysfunction in Parkinson's disease. Neurology. 1986; 36(1):73-5. DOI: 10.1212/wnl.36.1.73. View